Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index, and 1 are not checked yet.

Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosa

Open access

Abstract

Hereditary retinal blindness is caused by mutations in genes expressed in photoreceptors or retinal pigment epithelium. Gene therapy in mouse and dog models of a primary retinal pigment epithelium disease has already been translated to human clinical trials with encouraging results. Treatment for common primary photoreceptor blindness, however, has not yet moved from proof of concept to the clinic. We evaluated gene augmentation therapy in two blinding canine photoreceptor diseases that model the common X-linked form of retinitis pigmentosa caused by mutations in the retinitis pigmentosa GTPase regulator ( RPGR ) gene, which encodes a photoreceptor ciliary protein, and provide evidence that the therapy is effective. After subretinal injections of adeno-associated virus-2/5–vectored human RPGR with human IRBP or GRK1 promoters, in vivo imaging showed preserved photoreceptor nuclei and inner/outer segments that were limited to treated areas. Both rod and cone photoreceptor function were greater in treated (three of four) than in control eyes. Histopathology indicated normal photoreceptor structure and reversal of opsin mislocalization in treated areas expressing human RPGR protein in rods and cones. Postreceptoral remodeling was also corrected: there was reversal of bipolar cell dendrite retraction evident with bipolar cell markers and preservation of outer plexiform layer thickness. Efficacy of gene therapy in these large animal models of X-linked retinitis pigmentosa provides a path for translation to human treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1118847109

Cites

61 of 62 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 61 references

Cited by

See all 272

Metadata

Authors
Beltran, W. A., Cideciyan, A. V., Lewin, A. S., Iwabe, S., Khanna, H., Sumaroka, A., Chiodo, V. A., Fajardo, D. S., Román, A. J., Deng, W.-T., Swider, M., Alemán, T. S., Boye, S. L., Genini, S., Swaroop, A., Hauswirth, W. W., Jacobson, S. G., & Aguirre, G. D.
Affiliations
  • University of Pennsylvania (US)
  • University of Florida (US)
  • University of Massachusetts Chan Medical School (US)
  • Department of Ophthalmology, Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104;
  • National Institutes of Health (US)
Venue
Proceedings of the National Academy of Sciences
Published
2012-01-23
Volume
109
Issue
6
Pages
2132-2137
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2038567516
Cited by
260
References
61
Citations by year
2026: 7 · 2025: 8 · 2024: 14 · 2023: 11 · 2022: 14 · 2021: 14 · 2020: 19 · 2019: 18 · 2018: 19 · 2017: 19 · 2016: 23 · 2015: 23 · 2014: 18 · 2013: 33 · 2012: 19
FWCI
11.97
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (UL1TR000064)
  • U.S. Public Health Service (2PNEY-018241)
  • National Eye Institute (P30EY021721, EY 06855, EY-007961, EY-021721, EY17549, R01EY007961, R01EY017549, R01EY006855, P30EY001583)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
Keywords
X-linked retinitis pigmentosa, gene therapy, RPGR, adeno-associated virus vectors, canine model, subretinal injection, outer plexiform layer, photoreceptor function, retinal pigment epithelium
MeSH terms
Animals, Blindness, Dogs, Eye Proteins, Genotype, Humans, Mutation, Phenotype, Retinitis Pigmentosa, Genetic Therapy, Open Reading Frames, Photoreceptor Cells, Vertebrate, Protein Transport, Genetic Diseases, X-Linked, Retinal Bipolar Cells, Mice, Opsins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosa. https://app.cochat.ai/papers/10.1073/pnas.1118847109
The paper
Beltran, W. A., Cideciyan, A. V., Lewin, A. S., Iwabe, S., Khanna, H., Sumaroka, A., Chiodo, V. A., Fajardo, D. S., Román, A. J., Deng, W.-T., Swider, M., Alemán, T. S., Boye, S. L., Genini, S., Swaroop, A., Hauswirth, W. W., Jacobson, S. G., & Aguirre, G. D. (2012). Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosa. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1118847109

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.